ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
August 09, 2021 08:00 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
Europe Anticoagulant Reversal Drug Market Report 2021-2027: Market Opportunities with Increasing Research Activities on Anticoagulant Reversal Drugs
July 20, 2021 04:03 ET
|
Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Europe Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User" report has been added to...
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
July 13, 2021 08:00 ET
|
ARCA biopharma, Inc.
rNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patientsTrial expanded to South America, with regulatory approvals for Argentina and BrazilTarget trial enrollment...
Worldwide Anticoagulants Industry to 2026 - Featuring Aspen Holdings, Bayer and Pfizer Among Others
July 07, 2021 04:33 ET
|
Research and Markets
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impact of COVID-19 with Ansoff Analysis" report has...
China Apixaban Market Report 2021: Analysis of Major Manufacturers 2016-2020, Prices 2020-2021 & Prospects 2021-2025
May 04, 2021 04:28 ET
|
Research and Markets
Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Apixaban Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The sales revenue of Apixaban...
Global Anemia and Other Blood Disorder Drugs Markets 2020-2030: Focus on Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia
March 25, 2021 05:18 ET
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Anemia and Other Blood Disorder Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
December 29, 2020 17:20 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be assessing the use of glycosaminoglycans (GAGs) for the...
Lui Franciosi Reviewing the Use of Sugar-Based Molecules as Potential Treatments for COVID-19
December 29, 2020 17:04 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing the pharmacological feasibility of using specific...
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
December 15, 2020 08:30 ET
|
ARCA biopharma, Inc.
rNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patients, including after availability of vaccinesrNAPc2 is the only novel compound being developed for COVID-19...
Global Pulmonary Arterial Hypertension (PAH) Drugs Market Report 2020: Increasing Awareness Regarding Available Treatment Alternatives to Drive Market Growth
December 01, 2020 05:18 ET
|
Research and Markets
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension (PAH) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been...